Starting Your Journey: What is the First Dose of Wegovy?

Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The initial semaglutide injection dose is carefully calibrated to help your body adjust to this GLP-1 receptor agonist without overwhelming your system. Clinical trials show that gradual dose escalation over 16 weeks produces the best outcomes for weight loss while minimizing side effects. Understanding what happens during your first week helps you manage expectations and stay committed to your personalized treatment plan.

Understanding Your Starting Semaglutide Dose

PlexusDx prescribes compounded semaglutide from licensed 503A pharmacies, and your first injection follows a proven escalation protocol. The typical starting dose is 0.25 mg, administered once weekly as a subcutaneous injection into your abdomen, thigh, or upper arm. This low initial dose allows your GLP-1 receptors to become activated gradually, reducing nausea and other adjustment symptoms that sometimes occur with higher starting amounts.

Your dose may need to go up over the coming weeks—your price won't. PlexusDx pricing remains flat whether you're on starter doses or therapeutic levels, starting at just $189 per month for compounded semaglutide injection. This transparent model removes the financial barrier that often prevents people from completing their full escalation schedule and reaching their weight loss goals.

How Your Body Responds to the First Injection

During the first 24 to 48 hours after your initial semaglutide injection, you may notice changes in appetite signals. The medication binds to GLP-1 receptors in your brain's satiety center, signaling fullness even when you consume smaller portions. Most patients report that food cravings diminish within the first week, making it easier to stick to a calorie-appropriate diet without feeling deprived.

Gastrointestinal adjustments are common but typically mild at starter doses. Some people experience slight nausea, constipation, or decreased appetite for certain foods—symptoms that often resolve within a few days as your system acclimates. Staying hydrated, eating smaller meals, and avoiding high-fat foods during your first week can ease this transition and help you feel more comfortable.

Why Gradual Escalation Matters for Long-Term Success

Clinical evidence from the STEP trials demonstrated that participants who followed a gradual 16-week dose escalation protocol achieved sustained weight loss of 15 to 18 percent of baseline body weight. Starting at 0.25 mg and increasing to 0.5 mg, 1 mg, and eventually 2.4 mg allows your body to build tolerance, maximize efficacy, and complete the full program without discontinuing due to side effects. This approach respects your body's natural adaptation capacity while delivering measurable metabolic improvement.

Your first four weeks at 0.25 mg establish the foundation for everything that follows. During this phase, your healthcare provider monitors your response and gathers data about how your unique GLP-1 and GIPR pathways respond to the medication. PlexusDx members can optionally add the Precision Peptide Genetic Test ($298) to identify your individual genetic predispositions across 14 metabolic pathways, enabling even more targeted dose optimization and predicted response rates.

Preparing for Your First Semaglutide Injection

Before administering your first dose, ensure you have all necessary supplies: your sterile semaglutide vial, alcohol wipes, a clean injection pen or syringe, and a sharps disposal container. Choose a consistent day and time each week—many patients select Monday or Wednesday to align with their routine. Inject into fatty tissue, rotating sites each week to prevent lipodystrophy (localized fat changes), and store your medication in the refrigerator at 36°F to 46°F.

Meal timing around your injection day also matters. Eating a light, low-fat breakfast before your injection can stabilize your blood sugar and reduce injection-site discomfort. In the hours following your first dose, maintain normal hydration and avoid strenuous exercise; gentle walking is fine. Keep a symptom diary for the first week to document nausea, appetite changes, or energy shifts—this information helps your PlexusDx provider optimize your next dose adjustment and personalize your ongoing protocol.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the exact dose in my first semaglutide injection?

Your first injection typically contains 0.25 mg of compounded semaglutide from a licensed 503A pharmacy. This starter dose activates your GLP-1 receptors without overwhelming your system, and you'll increase gradually over 16 weeks based on your individual response and tolerance.

How does semaglutide work at the cellular level during your first dose?

Semaglutide binds to GLP-1 receptors located in your brain's hypothalamus, pancreas, and intestines, signaling satiety and slowing gastric emptying. Your first dose begins this signaling cascade within hours, which is why appetite suppression often appears within 24 to 48 hours, even at low starter doses shown in clinical trials.

Does PlexusDx charge more as my dose increases?

No. PlexusDx pricing is flat regardless of dose escalation—your compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and remains that price as your dose increases. This transparent model removes financial barriers and encourages patients to complete their full 16-week escalation protocol without cost surprises.

Is nausea from the first dose dangerous or a sign to stop?

Mild nausea is common but typically not dangerous and does not require stopping treatment. It usually resolves within a few days as your body adapts. If nausea persists or worsens, contact your PlexusDx provider immediately—they can adjust your meal timing, hydration, or protocol to help you tolerate the medication safely.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Victoza Starting Dose
• Trulicity Starting Dose
• Liraglutide Starting Dose
• Glp 1 Starting Dose

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.